Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
AdAlta Ltd. ( (AU:1AD) ) just unveiled an update.
AdAlta Ltd has released its holdings range report as of June 4, 2025, detailing the distribution of its listed options expiring in 2028. The report shows that a significant majority of the issued share capital, 97.74%, is held by a small number of large stakeholders, with SACAVIC PTY LTD holding the largest portion at 17.30%. This concentration of ownership could impact the company’s strategic decisions and market influence.
More about AdAlta Ltd.
AdAlta Ltd is a company operating in the biotechnology industry, focusing on the development of novel therapeutic products. The company is involved in creating innovative treatments, potentially targeting unmet medical needs in various markets.
Average Trading Volume: 957,709
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.22M
Find detailed analytics on 1AD stock on TipRanks’ Stock Analysis page.